Abstract

Modern oncology operates on a reactive, disease-centric model. While this framework excels at treating established pathology with standard therapies, it largely ignores the root molecular mechanisms that trigger cancer onset. 

By prioritizing late-stage interventions—like targeting gene expression products, proteins and trying to kill cancer cells, this approach yields a dismal 11% five-year progression-free survival rate. 

For the vast majority of patients, it remains financially unsustainable, drives up treatment costs, and often leads to recurrence, high mortality, and severe collateral organ damage that degrades overall healthspan.

This structural vulnerability became glaringly obvious during India’s 2018 healthtech boom. Rushing to capitalize on rising cancer rates, new healthtech and DNA startups faced intense venture capital pressure. 

Instead of innovating, they simply replicated flawed Western frameworks, pairing legacy diagnostic methods with basic digital delivery. Funding was aggressively funneled into hardware, wet labs, and aggressive user acquisition rather than deep-tech innovation or longitudinal clinical validation rooted in the bioenergetic view of cancer. 

Today, the consequences are clear: many of these testing companies are shutting down, surviving solely on investor lifelines, or facing distress acquisitions at a mere 10% to 20% of their peak valuations. This blog explores these systemic vulnerabilities and outlines a strategic shift to align deep clinical validation with scalable commercial application.

The dominant yet flawed theory of cancer-DNA mutations

For decades, oncology has been anchored in the Somatic Mutation Theory (SMT)—the premise that random DNA errors are the root cause of cancer. This framework dictates today’s standard of care: PET scans detect the tumors, genomic sequencing identifies the genetic flaws, and chemotherapy, radiation, or immunotherapy are deployed to destroy the malignant cells.

Despite these efforts, this mutation-centric approach is hitting a wall. The overall five-year survival rate for advanced cancer remains stubbornly low, and for devastating diagnoses like glioblastoma, it plummets to less than 3%.

Data reveals that our failure to improve survival rates stems from a reductionist biological approach. By narrowly targeting specific “driver” mutations which, paradoxically, are also found in perfectly healthy tissues—conventional treatments frequently cause systemic damage, disrupting the normal function of vital organs(1).

Furthermore, the highly praised promises of “molecularly targeted” therapies and “precision” medicine often trigger severe, life-threatening consequences, including:

• Treatment Failure: Accelerated drug resistance, cancer relapse, and aggressive metastasis(1).
• Systemic Toxicity: Severe wasting conditions (anorexia, cachexia, sarcopenia), blood disorders (leukopenia, thromboembolism), and ultimate multi-organ failure(1).

This precision approach is inherently imprecise because it fails to account for intertumoral and intratumoral heterogeneity. By targeting only a few select mutations, gene expressions, or proteins, these drugs leave alternative cellular pathways wide open. Cancer cells easily bypass the blockade, resulting in unbridled proliferation(1).

To make real progress, we must recognize that DNA mutations are not the starting point; they are a downstream epiphenomenon of a much more fundamental crisis: the breakdown of mitochondrial energetic processes.

The missing piece in modern oncology is the bioenergetic view of cancer. At the very center of this paradigm shift lies the mitochondria. Far more than just the “powerhouse of the cell,” the mitochondrion acts as the ultimate master regulator, orchestrating the vital cellular functions and decisions that sustain life.

Mitochondria: the biocomputing network deciding the fate of cancer cells

For decades, we believed mitochondria’s only job was converting biochemical energy into electrochemical ATP to fuel daily cellular tasks—like synthesizing proteins, activating enzymes, or producing hormones like vitamin D, insulin, and cortisol. However, groundbreaking research is flipping this paradigm on its head. We now know that mitochondria aren’t just powerplants- they are cell controllers- they decide the fate of cells-whether they have to remain quiescent ,grow,divide, senescent or die. This fate of cells is driven by huge communication networks & signals such as cytokines, mitokines & mitibokines mitochondria secrete. These signals communicate with other mitochondria & cells, telling about the state of metabolic reactions & stress, driving allostatic adaptation & shifts

It has also been found that mitochondria communicates with the nucleus of the cells via signalling, instructing them to turn on or turn off specific genes that drive epigenetic modifications & program our biology for health or disease.

Remarkably, mitochondria even have their own DNA. When they experience severe stress, they can leak this genetic material, which can integrate into our nuclear DNA—a cellular distress signal that often marks the onset of disease.

Application of quantum physics in mitochondrial biology(2)

Mitochondria Aren’t Just Power Plants—They’re Electrical Circuits

We usually learn that mitochondria are the “powerhouses” of our cells, turning the food we eat into ATP (the body’s energy currency). But beneath the surface, your biology operates much like a complex electrical grid—one governed by the same physics principles that run your smartphone battery, including Ohm’s Law.

In simple terms, electrical current relies on resistance to control the flow of energy. Your mitochondria do the exact same thing.

Inside the mitochondrial Electron Transport Chain (ETC), electrons flow across a gradient toward oxygen. As these electrons encounter “resistance” along the way, energy is captured and transformed into ATP. In fact the ion channels, whose movement drives & controls the bioelectric pattern, the voltage gradient of cells, resides in the mitochondrial inner & outer membrane & is controlled by mitochondrial functions. In effect, mitochondria modulates these bioelectric patterns via controlling movement of ion channels, thereby impacting proliferation, differentiation, migration, and apoptosis of cells.

The Maths & physics Behind Cellular Energy

We can actually frame mitochondrial efficiency using a bioenergetic formula for Variable Resistance:

variable resistance = demand/(current flux)^2

Here  demand= supply of electrons ; current = flux of electrons.

Think of this as a dynamic balancing act shaped by three core factors:

1. Energy Demand (The Supply of Electrons): Driven by your body’s signals (like hormones or the gut-brain axis), this reflects how much energy your organs need. It dictates how many electrons from glucose and fatty acids are pushed into the system.
2. Current Flux (The Rate of Electron Flow): This is how fast electrons travel to their final acceptor—oxygen. Factors like blood flow, cofactors (such as NAD+), and gut & oral microbial metabolites dictate this speed. (Note: The flux is squared because cellular energy dynamics scale exponentially, not linearly).
3. Variable Resistance (The Biological Brakes): This arises from natural biochemical constraints. It ensures energy is released smoothly rather than all at once.

The Danger of Extremes

Energy transformation requires a delicate balance. What happens when the formula breaks down?

• High Resistance (The Jammed Circuit): If inflammation, toxins, or environmental stressors slow down electron flux, the denominator drops toward zero. Resistance spikes to unsustainable levels. Electrons back up and leak onto oxygen molecules, creating damaging Reactive Oxygen Species (ROS) that harm DNA, RNA, and proteins.
• Oversupply (The Overloaded Line): Elevated insulin or disrupted hunger hormones (like ghrelin) flood the system with too many electrons. This overload drives resistance through the roof, stressing the whole pathway.
• Zero Resistance (The Short Circuit): On the flip side, if there were zero physical or biological resistance, energy would discharge instantaneously. Without “brakes,” the cell would essentially combust, releasing heat with zero usable work.

Ultimately, healthy metabolism isn’t about eliminating resistance entirely—it’s about maintaining a Goldilocks Zone. By keeping electron flux steady and demand balanced, your cellular circuits can produce optimal ATP without blowing a fuse.

The disruption in electron flow is starting point of cancer 

We each operate on a fixed daily energy budget. But when our cells face constant modern stressors—like exposure to toxins, chronic inflammation, gut/ oral microbial metabolites or hormonal swings—our mitochondria (the cellular powerhouses) start to sweat.

To sound the alarm, stressed mitochondria release signaling molecules called cytokines. This triggers an emergency protocol: the body steals energy away from long-term maintenance, growth, and repair to fight the immediate threats. Scientists call this shift a new allostatic state.

If these stressors never go away, your cells enter a state of chronic high-energy expenditure—or hypermetabolism. Eventually, this leads to total systemic overload and a breakdown in cellular communication.

At the quantum level, this energy bottleneck creates severe friction. Electrons back flow along the mitochondrial chain and leak onto molecular oxygen. The result?

• Impaired ATP (energy) production
• Excess heat generation
• A spike in harmful free radicals (ROS)

Starved of basic energy, critical cellular pumps like the Sodium-Potassium pump fail. Sodium floods into the cell, potassium drains out, and the cell loses its transmembrane potential, shifting to a depolarised state. At the same time, calcium overloads the system, creating an electrostatic wall that completely shuts down communication with neighboring cells.

Severed from the collective body, the isolated cell abandons its normal duties and reverts to a selfish, primitive survival mode—and that is how cancer begins.

Unable to generate energy through normal mitochondrial channels, these rogue cells resort to an emergency backup: fermenting glucose and glutamine, even when oxygen is available. This metabolic pivot is the famous Warburg Effect.

The molecular factors influencing variable resistance & triggering onset of cancer(2)

When your cells experience high “variable resistance”—triggered by chronic inflammation and toxins—it creates a perfect storm for metabolic dysfunction, cancer, and premature aging.

Here is how the bioenergetic cascade unfolds, and how we can reverse it.

The Domino Effect: How Cellular Resistance Triggers Cancer

1. Energy Loss & Cellular Heat High resistance inside the cell chokes off ATP (energy) production. Instead of clean energy, the cell produces excess heat. This heat causes proteins to misfold, damages cellular structures, and emits stress signals (reactive oxygen species and biophotons). Over time, this cumulative damage mutates DNA and RNA.The Takeaway: The genetic mutations most cancer treatments target aren’t the root cause—they are the epiphenomenon of failing mitochondria.
2. The Shift to Reductive & Oxidative Stress As electrons face excessive resistance in the mitochondrial transport chain, they back up like traffic. Electrons flow backward, converting NAD⁺ to NADH. This shift creates reductive stress, forcing the electron transport chain to “leak” electrons onto oxygen and triggering oxidative stress. This double-whammy destroys cellular communication and dictates cell fate.
3. The Warburg Effect (Fermentation Over Function) A skewed NADH/NAD⁺ ratio stalls the Krebs cycle. Backed-up pyruvate is converted into lactate by lactate dehydrogenase—a hallmark of aerobic glycolysis (the Warburg Effect). Deprived of normal respiration, cells detach from the body’s regulatory systems and revert to an ancient, primitive energy strategy: fermentation.
4. Metastasis: Rogue Macrophages Spread the Fire In a desperate attempt to heal this localized metabolic damage, immune cells (macrophages) fuse with these dysregulated cancer cells. Because macrophages are naturally programmed to travel freely throughout the body, these “rogue” hybrid cells gain the ability to migrate, giving rise to metastasis.

Restoring Mitochondrial Flow: A Bioenergetic Blueprint

To prevent or reverse this cascade, the goal is simple: decrease cellular resistance by managing electron supply and optimizing electron flux.

1. Control the Electron Supply

• Optimize Metabolic Hormones: Rebalance insulin, ghrelin, leptin, thyroid, and testosterone.
• Incorporate Fasting: Time-restricted eating regulates energy input and relieves cellular pressure.

2. Clear the Resistance (Improve Electron Flux)

• Clean Up the Microbiome: A healthy gut & mouth reduces systemic metabolic load.
• Minimize Toxin Exposure: Reduce exposure to mold, glyphosate, pesticides, and environmental pollutants.

3. Advanced Regenerative Strategies

• Boost NAD⁺ Biosynthesis: Replenish NAD⁺ pools while dampening inflammatory cascades with targeted antioxidants.
• Support Creatine Kinase: Restore cellular energy buffering systems.
• Re-open Cellular Channels: Utilize precision therapeutics to restore gap junction communication.
• Trigger Mitophagy: Use specific postbiotics to clear out broken mitochondria and build new ones.
• Elevate Beta-Hydroxybutyrate (Ketones): Fuel mitochondria efficiently with ketone bodies while starving cancer cells of fermentable sugars.

By shifting our perspective from “killing mutations” to restoring bioenergetic balance, we unlock a far more precise, regenerative approach to longevity and cancer prevention.

Bridging the gap to revolutionise cancer prevention

The failure of the standard of care approach for early detection & treatment adopted by cancer testing companies & hospitals is reflected in data related to 5 year survival rates. To bring a paradigm shift in treatment of cancer necessitates a relook at cancer prevention strategy

1. Shift Primary Focus to Mitochondrial Health

• Rather than relying solely on genetic sequencing to detect downstream mutations, measure metabolic stress pathways, variable resistance, and early inflammatory cytokine spikes.
• Detects cellular displacement before structural tumors manifest.
• Do not focus on setting up wet lab alone, rather develop interpretation layer that could translate the cellular, mitochondria & multiomics data into actionable, measurable & interpretable pathways

2. For At-Risk Individuals

• Implement precision nutrition and targeted regenerative therapies designed to decrease cellular resistance, stimulate mitophagy (clearance of damaged mitochondria), and promote mitochondrial biogenesis.
• Use longitudinal bioenergetic tracking to evaluate real-time cellular response to interventions.

3. For Diagnosed Cancer Patients

• Instead of relying exclusively on standard cytotoxic protocols—which show low long-term efficacy (<11%)—integrate therapies that restore gap junction communication and re-establish bioelectric connectivity across cell populations.
• Combine bioenergetic stabilization with calibrated, low-dose conventional therapies to eliminate remaining rogue cells, particularly during metastatic stages.

Citations

(1).Maeda, H., Khatami, M. Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs. Clin Trans Med 7, 11 (2018). https://doi.org/10.1186/s40169-018-0185-6

(2) Picard M, Murugan N The energy resistance principle Cell Metabolism, 2025; 37, 2107-2127; https://doi.org/10.1016/j.cmet.2025.09.002